Company Information

Founded in
Gene editingLife sciencesOncologyT-Cell therapiesgenome engineeringallogeneicoff-the-shef CART therapies
Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 21 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its proprietary gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells. As part of its commitment to a cure, Cellectis remains dedicated to its goal of providing life-saving UCART product candidates to address unmet needs for multiple cancers including acute myeloid leukemia (AML), B-cell acute lymphoblastic leukemia (B-ALL), multiple myeloma (MM), Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Cellectis headquarters are in Paris, France, with additional locations in New York, New York and Raleigh, North Carolina. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more about us, visit our website: To learn more about our community guidelines, visit: Follow our other social media accounts: @cellectis on Twitter and Cellectis YouTube TALEN® is a registered trademark owned by the Cellectis Group.

Cellectis has 168 contacts, the majority of which in AroundDeal database are in Operations.


Sign Up to View Cellectis’s Top Employees

5 free contacts every month.

Start with AroundDeal For Free!

Use AroundDeal to build prospect lists in 1 click.

5 free contacts every month.

Get Contact Info for All Employees


Carrie Brownstein

Chief Medical Officer

Steve Doares

SVP & Site Head, US Manufacturing

Tim Sullivan

Director, Compensation, Benefits and Recruiting

Pierre Charvet

Supply Chain Manager

Dan Bright

Director Of Manufacturing Operations